Hint mode is switched on Switch off
For swift navigation between sections

Organization: Idorsia
LEI 506700XOVZUB107S5720

Organization name
Idorsia Ltd
Country name
Switzerland
Country of registration
Switzerland
Industry
Pharmaceutical Preparation and Biotechnology
Bond debt
895 mln USD

explore the most comprehensive database

800 000

bonds globally

Over 400

pricing sources

80 000

stocks

9 000

ETF

track your portfolio in the most efficient way

  • Bond Search
  • Watchlist
  • Excel ADD-IN
×

— Are you looking for the complete & verified bond data?

— We have everything you need:

full data on over 700 000 bonds, stocks & ETFs; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.

Register
×

Why

You will have detailed descriptive & pricing data for 650K bonds, 76K stocks, 8K ETFs
Get full access to the platform from any device & via Cbonds app
Enhance your portfolio management with Cbonds Excel Add-in
Build yield maps, make chart comparison within a click
Don't wait any longer — start using Cbonds today! Register

Latest data on

Quotes

Request sent
Access denied
Quotes provided by information providers are indicative in nature

Profile

Idorsia is an independent biopharmaceutical company based on science and innovation. The company is specialized in the discovery and development of small molecules, to transform the horizon of therapeutic options. Idorsia was incorporated in March 2017 and listed on the SIX Swiss Exchange.

Awards

Documentation

Stocks

Latest issues

Bond debt by currency

Codes

  • LEI
    506700XOVZUB107S5720
  • UID
    CHE340129854

Credit and ESG Ratings

Macroeconomic Indicators - Idorsia

Registration is required to get access.